• Sign Up
  • |
  • Sign In Sign Out
  • |
  • Make us your home
  • |
  • RSS
1 2
1 15
1 4
1 9
1 13
1 25
IPO
1 5015
1 5013
  • NDTV Profit launches 'Ideas For Change' campaign
  • Send suggestions to ideasforchange@ndtv.com
  • Join the NDTV Profit Campaign for change
  • email us at ideasforchange@ndtv.com
  • Nov ISM Non-Manufacturing Index falls to 37.3
  • Crude oil inventories for wk ended Nov 28 dn 456,000 bbl
  • Expect all responsible nations to cooperate
  • Not going to speculate on investigations into 26/11
  • Terrorists behind Mumbai attack came from Pakistan
  • U.S. will work closely with India in anyway it can
  • India's action will depend on response from Pakistan
  • New Maharashtra CM to be announced tomorrow
  • Congress accepts Maha CM Deshmukh's resignation
  • Commodities to remain under pressure as economies slow
  • Q3 Productivity rises 1.3%; Labour costs up 2.8% (QoQ)
  • Asks telecom department about spectrum, licence: NW
  • Seeks telecom department's reply on 3G, M&A: NW
  • NDTV Profit Campaign: ideasforchange@ndtv.com
  • Mumbai Terror: NDTV launches campaign for change
  • Inflation for wk ended Nov-22 seen at 8.95% vs 8.84% (WoW)
  • Continue to believe that deal is not taxable in India
  • Confident of a positive outcome of the case: Vodafone
  • Reviewing capex plans due to economic slowdown: NW
  • See delay in technology infra development: NW
  • Cost cutting measures already in place: NW
  • SAIL cuts prices by Rs.1200-1600/tn in certain products
  • We keep looking for opportunities: Essar
  • We do not comment on specific projects or speculations
  • MFs net sell Rs.326.8cr in equity on December 2
  • Court slots next hearing on 10th December
Updated: 04/12/08 | 12:33 AM IST
Pharma
After several quarters of sluggish growth, there’s some ray of hope for Dr Reddy's Laboratories, India's second largest drug maker by sales.
Comments: Read (0) Post
Sun Pharmaceutical today said it has acquired US-based drug ingredients manufacturer Chattem Chemicals for an undisclosed amount.
Comments: Read (0) Post
Global pharmaceutical giant AstraZeneca on Thursday said it will slash about 1,400 jobs in the coming years across Europe, as part of the restructuring plan of its manufacturing and supply chain operations.
Comments: Read (0) Post
Daiichi Sankyo today said it had achieved closure of the final transfer of shares from the Ranbaxy promoters, the Singh family, to itself, thereby upping its stake to 63.92 per cent in Ranbaxy Laboratories.
Comments: Read (0) Post
The deepening global financial crisis is forcing a bitter pill down the throat of Indian drug makers with companies pruning their ambitious R&D plans.
Comments: Read (0) Post
After Ranbaxy Laboratories, another major Indian drug maker, Sun Pharmaceuticals, is under the United States Food and Drug Administration’s scanner.
Comments: Read (0) Post
The Lipitor deal had further added to the speculation of Pfizer picking up a stake in Ranbaxy. But Pfizer on Wednesday told NDTV that it has no intention of picking up stake in Ranbaxy.
Comments: Read (0) Post
Global Crisis
GM to slash up to 31,500 jobs in US
General Motors told lawmakers that it plans to cut up to 31,500 more jobs in the United States, as it confronts a severe slump that has it begging Congress for a $18-billion bailout.

 
Market Watch
Graphs
Stocks
 
Trading Calls
Hemen Kapadia
Hemen Kapadia
5.44% status
Current: Rs 191.9
Ashu Kakkar
Ashu Kakkar
1.62% status
Current: Rs 1413.8
Simi Bhaumik
Simi Bhaumik
3.09% status
Current: Rs 507.9
Stock Recos
The counter is in the heavily oversold zone
I advice the investor to hold the stock with a 2-3 years perspective